Eltrombopag-chem-structure.jpg (Eltrombopag Chem Structure)
Eltrombopag Tablet
Product Images NDC 0054-0964
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 0054-0964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
12.5 mg Bottle Label (Eltrombopag 12 5mg Bl)
This is a description of a medication labeled with the NDC code 0054-0962-13. It contains 30 tablets to be stored at room temperature. The medication is eltrombopag, distributed by Hikma Pharmaceuticals USA. The dosage instructions are to swallow the tablets whole and not to split, chew, or crush them. Safety closures are recommended when dispensing the product. Each tablet contains eltrombopag olamine by Hikma, equivalent to 2.5 mg of eltrombopag free acid. The text also mentions a missing safety seal under the cap and advises to keep the product out of reach of children. Additional prescribing information is available separately.*
25 mg Bottle Label (Eltrombopag 25mg Bl)
This is a pharmaceutical label providing instructions for Eltrombopa tablets. It advises to swallow the tablets whole without splitting, chewing, or crushing them. The tablets should be stored at room temperature. Additionally, the text mentions the manufacturer and distributor information. Dosage information and specific warnings are also included on the label. Each tablet contains eltrombopag olamine equivalent to 25 mg of eltrombopag free acid.*
50 mg Bottle Label (Eltrombopag 50mg Bl)
This is a description of a medication labeled as NDC 0054-0964-13, which consists of 30 tablets of Eltrombopag. The instructions advise swallowing the tablets whole without splitting, chewing, or crushing them. It should be stored at room temperature and dispensed in the original bottle between 20°C to 25°C (68°F to 77°F). The manufacturer is Zonara Pharma Privato Limited, and it is distributed by Hikma Pharmaceuticals USA Inc. Each tablet contains Eltrombopag olamine equivalent to 50 mg of eltrombopag free acid. Safety precautions include not using the product if the printed safety seal under the cap is broken or missing, using safety closures, and keeping the medication out of reach of children.*
75 mg Bottle Label (Eltrombopag 75mg Bl)
This text provides information about a medication labeled as NDC 0054-0965-13, containing 30 tablets of eltrombopag olamine, each equivalent to 75 mg of eltrombopag free acid. It specifies storage at room temperature and advises against using the product if the safety seal is broken or missing. The text also directs users to swallow tablets whole and not to split, chew, or crush them. Additionally, it mentions the importance of using safety closures when dispensing the medication and provides guidance on dosages as per the accompanying prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
